XML 23 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income attributable to the Company $ 80,384 $ 40,591 $ 71,628
Adjustments to arrive at net income/(loss) from continuing operations      
Less: Net income attributable to noncontrolling interests 3,487 4,468 4,157
Net income from discontinued operations (2,002) (4,870) (5,541)
Net income from continuing operations 81,869 40,189 70,244
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:      
Depreciation and amortization 23,129 21,023 23,441
Net income attributable to noncontrolling interests (3,487) (4,468) (4,157)
Stock compensation, net of cancellations 6,676 8,275 4,112
Impairment of goodwill 0 24,901 9,528
Provision/ (credit) for loan losses (2,198) (7,669) (6,935)
Loans originated for sale (37,631) (53,287) (80,539)
Proceeds from sale of loans held for sale 39,773 52,508 85,814
(Gain)/loss on sale of affiliates or offices (18,142) 1,264 (2,862)
Goodwill and intangibles on sale of affiliate 18,919 0 0
Deferred income tax expense/ (benefit) 5,829 22,845 2,777
Net decrease/ (increase) in other operating activities (23,240) (8,466) (817)
Net cash provided by/ (used in) operating activities of continuing operations 91,497 97,115 100,606
Net cash provided by operating activities of discontinued operations 2,002 4,870 5,541
Net cash provided by operating activities 93,499 101,985 106,147
Investment securities available-for-sale:      
Purchases (39,747) (111,755) (382,827)
Sales 53,412 81,221 11,135
Maturities, redemptions, and principal payments 120,523 120,546 165,768
Investment securities held-to-maturity:      
Purchases (21,752) (14,945) 0
Principal payments 25,598 32,912 22,522
Equity securities at fair value:      
Purchases (63,791) (65,266) (39,488)
Sales 70,357 67,186 38,914
(Investments)/ distributions in trusts, net 224 (952) (508)
Purchase of BOLI 0 (50,000) 0
Contingent Considerations from Divestitures 1,233 0 0
Redemption of FHLB and FRB stock 10,710    
Purchase of FHLB and FRB stock   (15,896) (8,896)
Net increase in portfolio loans (390,884) (390,003) (403,670)
Proceeds from recoveries of loans previously charged-off 3,266 5,197 10,461
Proceeds from sale of OREO 108 1,644 1,337
Proceeds for sale of affiliates, offices and related deposits 52,981 0  
Payment for sale of affiliates, offices and related deposits     (98,517)
Capital expenditures, net of sale proceeds (20,643) (14,204) (9,011)
Net cash provided by/ (used in) investing activities (198,405) (354,315) (692,780)
Cash flows from financing activities:      
Net increase in deposits 270,924 425,100 148,303
Net (decrease)/ increase in securities sold under agreements to repurchase 4,759 (27,455) 1,409
Net increase/ (decrease) in federal funds purchased 220,000 (50,000) 80,000
Net (decrease) in short-term FHLB borrowings (220,000)    
Net increase in short-term FHLB borrowings   40,000 310,000
Advances of long-term FHLB borrowings 116,444 50,110 134,779
Repayments of long-term FHLB borrowings (169,981) (130,634) (171,898)
Repurchase of Series D preferred stock, including deemed dividend (50,000) 0 0
Repurchase of common stock (20,000) 0 (9,323)
Dividends paid to common shareholders (40,685) (37,054) (33,110)
Dividends paid to preferred shareholders (1,738) (3,475) (3,475)
Tax benefit/ (deficiency) from certain stock compensation awards 0 0 (620)
Proceeds from warrant exercises 372 3,003 0
Proceeds from stock option exercises 1,661 882 1,725
Proceeds from issuance of common stock 1,866 1,601 1,579
Tax withholding for share based compensation awards (2,430) (1,430) (737)
Distributions paid to noncontrolling interests (3,354) (4,360) (4,054)
Other equity adjustments 3,786 26 (82)
Net cash provided by financing activities 111,624 266,314 454,496
Net increase/ (decrease) in cash and cash equivalents 6,718 13,984 (132,137)
Cash and cash equivalents at beginning of year 120,541 106,557 238,694
Cash and cash equivalents at end of year 127,259 120,541 106,557
Supplementary schedule of non-cash investing and financing activities:      
Cash paid for interest 58,548 33,727 27,415
Cash paid for income taxes, net of (refunds received) 20,541 32,159 33,078
Change in unrealized gain/ (loss) on securities available-for-sale, net of tax (9,077) 4,497 (11,689)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 54    
Change in unrealized gain/ (loss) on cash flow hedges, net of tax   878 518
Change in unrealized gain/ (loss) on other, net of tax 296 50 123
Transfer of net assets into held for sale 21 58,034 0
Loans charged-off (899) (863) (3,949)
Loans transferred into/(out of) OREO from/(to) held for sale or portfolio $ 401 $ 0 $ 1,944